- Neonatal-Perinatal Medicine: University of Miami
- Pediatrics: Rutgers, Robert Wood Johnson Medical Center
- University Colegio Mayor del Rosario, Bogota, Colombia
- American Board of Pediatrics
- Sub-Board of Neonatal-Perinatal Medicine
- Stabilization and transport of critically ill infants
- International health
- History of medicine
- Neonatal brain injury
Dr. Ladino has cultivated an interest in the study of clinical variables that contribute to neonatal brain injury. He is working to evaluate the impact of high and low oxygen levels, as well as different glucose concentrations, on neonatal neurodevelopment and brain injury. That has involved the design of an in vitro neuronal cell model as well as in vivo clinical studies in animal models. He is a co-investigator in a study assessing the effectiveness of recombinant protein therapy in combating the neurological deficits caused by neonatal stroke. He has also been active in evaluating therapies to treat pulmonary hypertension in septic neonates, including the use of nitric oxide and small molecules delivered via different modes of administration.
More recently, Dr. Ladino has been directing a multidisciplinary team tasked with reducing the incidence of nosocomial infections in the NICU. Leading a multidisciplinary team of clinicians, Dr. Ladino has instituted changes in clinical practice which have led to a dramatic reduction in the incidence of catheter-associated blood stream infections (CABSI).